Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Mallinckrodt
Teva
Chinese Patent Office
US Army
Boehringer Ingelheim

Generated: June 19, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 206863

« Back to Dashboard

NDA 206863 describes DALFAMPRIDINE, which is a drug marketed by Accord Hlthcare, Actavis Labs Fl Inc, Alkem Labs Ltd, Aurobindo Pharma Ltd, Micro Labs, and West-ward Pharms Int, and is included in six NDAs. It is available from four suppliers. Additional details are available on the DALFAMPRIDINE profile page.

The generic ingredient in DALFAMPRIDINE is dalfampridine. There are ten drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the dalfampridine profile page.
Summary for 206863
Tradename:DALFAMPRIDINE
Applicant:Accord Hlthcare
Ingredient:dalfampridine
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 206863
Mechanism of ActionPotassium Channel Antagonists
Suppliers and Packaging for NDA: 206863
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DALFAMPRIDINE dalfampridine TABLET, EXTENDED RELEASE;ORAL 206863 ANDA Accord Healthcare Inc. 16729-292 16729-292-12 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (16729-292-12)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength10MG
Approval Date:Jul 11, 2018TE:ABRLD:No
Regulatory Exclusivity Expiration:Mar 9, 2019
Regulatory Exclusivity Use:PATENT CHALLENGE

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Cipla
UBS
US Department of Justice
Citi
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.